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Inactivation of the Pten tumor suppressor negatively
regulates the PI3K-mTOR pathway. In a model of
cutaneous squamous cell carcinoma (SCC), we
demonstrate that deletion of Pten strongly elevates
Fgf10 protein levels without increasing Fgf10 tran-
scription in vitro and in vivo. The translational activa-
tion of Fgf10 by Pten deletion is reversed by genetic
disruption of the mTORC1 complex, which also
prevents skin tumorigenesis in Pten mutants. We
further show that ectopic expression of Fgf10 causes
skin papillomas, whereas Pten deletion-induced skin
tumors are inhibited by epidermal deletion of Fgfr2.
Collectively, our data identify autocrine activation of
FGF signaling as an essential mechanism in pro-
moting Pten-deficient skin tumors.INTRODUCTION
Squamous cell carcinoma (SCC) is the second-most common
form of skin cancer (Ridky and Khavari, 2004). Mouse genetic
studies have demonstrated that skin SCC can be induced by
epidermal deletion of Pten, a critical tumor suppressor gene
implicated in multiple types of cancer (Suzuki et al., 2003).
Consistent with these data, germline mutations in various types
of the PTEN hamartoma tumor syndrome (PHTS) are known to
predispose patients to skin tumorigenesis (Eng, 2003). In addi-
tion to gene deletion,Pten function can bemanipulated in cancer
cells by other mechanisms such as transcription, microRNA,
translation, protein stability, promoter methylation, and by
various posttranslational events (Song et al., 2012). Indeed,
although somaticPTENmutations have not been found in human
SCCs, PTEN expression is shown to be frequently downregu-
lated by a GRHL3-mediated microRNA network (Agrawal et al.,
2011; Darido et al., 2011; Stransky et al., 2011). Skin SCC
observed in Pten-deficient animals has been reproduced by818 Cell Reports 6, 818–826, March 13, 2014 ª2014 The Authorstransgenic overexpression of activated AKT or RHEB in the
epidermis and blocked by inhibition of class Ia phosphatidylino-
sitol 3-kinase (PI3K) (Lu et al., 2010; Segrelles et al., 2007; Wang
et al., 2013), demonstrating the importance of PI3K-AKT-
mammalian target of rapamycin (mTOR) signaling in Pten-
induced tumorigenesis. Recent evidence suggests that mTOR
signaling controls the translation of nearly all mRNAs to some
extent, but its direct targets critical for tumorigenesis remain
poorly understood (Hsieh et al., 2012; Thoreen et al., 2012).
Fibroblast growth factor (FGF) signaling is required for
epidermal growth, skin barrier formation, and hair-cycle activa-
tion (Greco et al., 2009; Grose et al., 2007; Yang et al., 2010).
Upregulation of ligands FGF2, FGF7, FGF10, and FGF22, and
their activation of FGFR2 signaling, has been shown to initiate
keratinocyte proliferation in diseased states such as acne, pso-
riasis, and wound healing (Braun et al., 2004). On the other hand,
although activating mutations in FGFR3 have been shown to
underlie benign skin tumors, including epidermal nevi or sebor-
rheic keratosis, epidermal deletion of Fgfr2 is shown to sensitize
animals to chemically induced skin papillomas and SCCs (Grose
et al., 2007; Logie´ et al., 2005). Therefore, FGF signaling plays
highly context-dependent roles in skin homeostasis and tumor-
igenesis (Turner and Grose, 2010). In this study, we show that
Pten loss in keratinocytes activates the translation of Fgf10 in
an mTOR-dependent manner. The resulting induction of FGF
signaling promotes skin papilloma formation, which can be
reversed by genetic ablation of Fgfr2 in the epidermis. Our re-
sults thus reveal an autocrine FGF signaling network induced
by Pten-mTOR signaling essential for skin tumorigenesis.
RESULTS
A Mouse Model of Pten-Regulated Skin Tumorigenesis
We generated an epidermal-specific ablation of Pten using
Le-Cre driver, which is known to be expressed in the ocular sur-
face but is also reportedly active in the anterior mandibular ecto-
derm (Ashery-Padan et al., 2000; Miller et al., 2006; Pan et al.,
2008). Indeed, 1-month-old Le-Cre;Ptenflox/flox (PtenCKO) animals
exhibited skin swelling both around the eyelid and in the cheek
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Figure 1. Pten Loss Initiates Hyperkera-
tosis in the Facial Epidermis
(A and B) Four-week-old PtenCKO mice displayed
hyperkeratosis in cheek and eyelid epidermis
(arrows).
(C and D) Paraffin sections of the skin revealed the
expansion of epidermal layers in PtenCKO mice
(arrow).
(E and F) X-gal staining indicated specific activity
of Le-Cre;R26R in the epidermis (arrows).
(G–L) PtenCKO mice exhibited a loss of Pten from
the epidermis (H, arrow), increased Ki67 staining
denoting proliferation of the basal layer (J, arrow),
and expansion of the suprabasal layer shown by
K10-positive staining (L, arrow).(Figures 1A and 1B, arrows). Histological sections revealed
epidermal hyperplasia, hypergranulosis, and hyperkeratosis,
which progressed to papilloma in severely affected animals (Fig-
ures 1C and 1D, arrows; data not shown). By crossing with R26R
Cre reporter, we showed that the Cre-positive cells stained by
X-gal were restricted to the epidermis and to hair follicles, con-
firming the specificity of Le-Cre to skin (Figures 1E and 1F,
arrows). Consistent with these results, PtenCKO epidermis dis-
played a marked reduction in Pten staining and strong increases
in cell proliferation markers Ki67 and phospho-Histone H3 (Fig-
ures 1G–1J; data not shown). K14-positive keratinocytes
remained within the single basal cell layer attached to the base-
ment membrane; however, the K10-labeled suprabasal layer
was greatly expanded (Figures 1K and 1L, arrows). These hyper-
plastic proliferation phenotypes resembled the onset of SCC
previously described in a pan-keratinocyte Pten deletion model
(Suzuki et al., 2003).
Pten Deletion Increased Fgf10 Protein Level in Skin
Epidermis
To gain insight into the role of FGF signaling in SCC, we per-
formed qPCR on the epidermal layer removed from PtenCKO
mice but found no significant increase in the mRNA levels of
Fgfs (Fgf1, Fgf2, Fgf7, and Fgf10) and Fgf receptors (Fgfrs)
(Fgfr1, Fgfr2, Fgfr3, and Fgfr4) (Figures 2A and S1A). Immuno-
blotting of the same samples confirmed depletion of Pten protein
and increased phosphorylation of AKT, 4EBP1, and S6, all
downstream effectors of the PI3K-mTOR pathway (Figure 2B).
Interestingly, although the protein levels of Fgf1, Fgf2, and Fgf7
remained low, immunoblotting of PtenCKO epidermis revealed a
significant increase in Fgf10 protein.
Fgf10 is known to be secreted by intraepithelial gd T cells in
response to epidermal wounding (Werner et al., 1994). However,Cell Reports 6, 818–82crossing PtenCKO mouse with TCRd/
animals that are unable to produce gdT
cells not only failed to reduce Fgf10 levels
but even accelerated tumorigenesis (data
not shown), suggesting that activation of
gd T cells cannot account for the increase
in Fgf10 protein in PtenCKO epidermis. We
next harvested primary keratinocytes
from neonatal Ptenflox/flox pups and sup-pressed Pten expression using Cre-expressing adenovirus.
Following viral infection, cells were either allowed to remain in
a basal state by culturing in low Ca2+ media (basal media) or
forced to differentiate into suprabasal cells by culturing in high
Ca2+ media (suprabasal media). Similar to results observed in
the in vivo model, qPCR of basal or suprabasal state keratino-
cytes showed no significant change in Fgf10 mRNA expression
upon Pten deletion, but pAKT, p4EBP1, and pS6 protein levels
were upregulated on immunoblotting (Figures 2C and S1B).
Importantly, immunoblotting for Fgf10 showed elevated levels
in Pten-depleted cells cultured in suprabasal media. Finally,
immunohistochemistry of tissue sections showed intense
staining of pAKT, pS6, p4EBP1, and Fgf10 in PtenCKO epidermis
(Figures 2D–2K). Taken together, these results suggested that
loss of Pten results in translational activation of Fgf10 in
keratinocytes.
We next examined whether these pathways derived from our
mouse model existed in human cells and SCCs. By siRNA-
mediated knockdown, we first depleted PTEN in primary human
keratinocytes. The results presented in Figure 2L show that in
both basal and suprabasal culture conditions, PTEN deficiency
led to an increase in AKT and S6 phosphorylation and elevated
FGF10 protein expression. We next analyzed PTEN and FGF10
expression in well-to-moderately differentiated human skin
SCC that arose spontaneously (n = 9) or developed after
undergoing transplantation procedures (n = 6) via immuno-
histochemistry. Normal skin tissue from patients undergoing
abdominoplasty was obtained for comparison (n = 6). Strikingly,
15 out of 16 of these SCC specimens showed a loss in PTEN and
an increase in FGF10 in the epithelial layer when compared to
normal skin tissue (p < 0.001) (Figures 2M–2S). This observation
was further confirmed in a SCC tissue array, where 42 out of 47
samples displayed elevated levels of FGF10 (data not shown).6, March 13, 2014 ª2014 The Authors 819
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Finally, we examined five poorly differentiated human SCC
samples and found that they all stained weakly for PTEN but
strongly for FGF10 (Figures 2O and 2R). These results thereby
emphasize the potential role of PI3K and FGF signaling in pro-
moting human skin SCC.
mTOR Signaling in the Epidermis Regulates Fgf10
Expression and Tumorigenesis
Pten-PI3K signaling is known to promote protein translation via
mTOR-mediated phosphorylation of translational suppressor
4EBP1. 4EBP1 phosphorylation activates cap-dependent trans-
lation of mRNA sequences containing a TOP-like motif, which is
defined as containing at least five pyrimidines near the transcrip-
tional start site (Hsieh et al., 2012; Thoreen et al., 2012). Interest-
ingly, among Fgf mRNAs we detected in keratinocytes, only
Fgf10 contains a TOP-like sequence immediately following its
transcriptional start site (Figure 3A), suggesting that translation
of Fgf10 may be uniquely regulated by mTOR signaling. It was
recently demonstrated that the allosteric inhibitor of mTOR,
rapamycin, suppresses phosphorylation of only a subset of
mTOR downstream targets, most notably S6K1 and its substrate
S6 (Kang et al., 2013). In contrast, the ATP-competitive mTOR
inhibitor, Torin, further blocks phosphorylation of T37 and T46
residues of 4E-BP1, sites that are rapamycin resistant. Because
TOP-like mRNA translation is mainly regulated through 4EBPs,
but not S6Ks (Kang et al., 2013; Pende et al., 2004), we hypoth-
esized that the Fgf10 TOP-like sequence may be sensitive to
Torin, but not to rapamycin. To test this idea, we cloned Fgf10
50 UTR into a GFP reporter, carrying either wild-type (WT) or
6 bp transversions within the TOP-like sequence (Figure 3A).
As expected, Torin treatment of NIH 3T3 cells abolished both
S6 and 4EBP1 phosphorylation and prevented expression of
the WT Fgf10 50 UTR-GFP reporter (wtTOP) (Figure 3B). How-
ever, both the vector control and the mutated Fgf10 50 UTR-
GFP reporter (mutTOP) were unaffected, demonstrating the
critical role of Fgf10 TOP-like sequence in mTOR-induced
translation. Although rapamycin treatment eliminated S6 phos-
phorylation, there was still significant 4EBP1 phosphorylation
in transfected NIH 3T3 cells. As a result, neither the WT nor the
mutant GFP reporters exhibit reduced expression. These results
support that 4EBP-mediated mTOR signaling controls the trans-
lational activity of Fgf10 TOP-like sequence.
Torin inhibits activities of both mTORC1 and mTORC2, two
distinct complexes of the mTOR kinase. To identify which
mTOR complex regulates Fgf10 expression in vivo, we crossed
PtenCKO mice with epidermal-specific knockouts of Raptor and
Rictor, which are obligatory components of mTORC1 and
mTORC2, respectively (Zoncu et al., 2011). Consistent withFigure 2. Loss of Pten Induces Fgf10 Protein but Not mRNA Expressio
(A) qPCR analysis of Fgf mRNA expressions in the mouse epidermis.
(B) Immunoblots of PtenCKOmice facial and cheek epidermis showed a reduction i
little changes in Fgf1, Fgf2, and Fgf7 expression, Fgf10 was strongly upregulate
(C) Pten-depleted keratinocytes switched from low to high Ca2+ media (basal to
(D–K) Immunohistochemistry confirmed strong pAKT, pS6, p4EBP1, and Fgf10 s
(L) siRNA-mediated PTEN depletion resulted in a significant increase of pAKT, p
(M–S) Both well-to-moderately and poorly differentiated human SCC stained we
epidermis. Data are presented as mean ± SEM.
See also Figure S1.the known function of mTORC2 as an AKT S473 kinase, Le-Cre;
Ptenflox/flox;Rictorflox/flox (PtenCKO;RictorCKO) epidermis com-
pletely lost AKTS473 phosphorylation (Figure 3C). The levels of
p4EBP1 and pS6, however, were unaffected by Rictor
deletion, whereas Fgf10 expression was moderately downregu-
lated. In contrast, Le-Cre;Ptenflox/flox;Raptorflox/flox (PtenCKO;
RaptorCKO) epidermis exhibited not only attenuated AKTS473
phosphorylation but also significant reduction in p4EBP1, pS6,
and Fgf10 levels (Figure 3C). As a result, epidermal hyper-
plasia observed in 1-month-old PtenCKO mice was reduced in
PtenCKO;RictorCKO littermates and completely prevented in
PtenCKO;RaptorCKO animals (Figures 3D–3P). Thus, mTORC1
signaling is critically required for Fgf10 expression and tumori-
genesis in Pten mutants.
Autocrine Fgf10-Fgfr2 Signaling Mediates Pten
Deletion-Induced Tumorigenesis
We next explored the functional significance of increased Fgf10
expression in Pten-deficient epidermis. We utilized an inducible
Fgf10 transgene (pMes-Fgf10) that places a LoxP-flanked tran-
scription STOP cassette between a constitutively active chick
b-actin promoter and an Fgf10 cDNA (Figure 4A) (Song et al.,
2013). Preliminary characterization of this transgene indicated
that, due to positional variegation, Cre-mediated excision of
STOP cassette typically results in a mosaic expression of
Fgf10 (data not shown). Nevertheless, all Le-Cre; pMes-Fgf10
mice at 3 weeks of age developed spontaneous papillomas,
which appeared as finger-like protrusions arising from epidermis
(Figures 4C–4F, arrows). Importantly, immunoblotting of tissue
lysates indicated that these nodules expressed higher levels of
Fgf10 than their adjacent skin control (Figure 4B). These results
demonstrate that overexpression of Fgf10 is sufficient to induce
epidermal hyperplasia and papilloma formation in a dose-
dependent manner.
Fgf10 is known to signal through primarily Fgfr2 and Fgfr1 to a
lesser extent (Zhang et al., 2006). We thus reasoned that if Fgf10
was a key downstream target of Pten-PI3K signaling, the tumor-
igenic phenotype in PtenCKO mice may be rescued by genetic
ablation of Fgfr2. Indeed, epidermal hyperplasia was only slightly
reduced in Le-Cre;Ptenflox/flox;Fgfr1flox/flox (PtenCKO;Fgfr1CKO)
mice, which still maintained high levels of AKT phosphorylation
and Fgf10 expression (Figures 4G, 4H, 4J, 4K, and 4M, arrows).
In contrast, pAKT and Fgf10 in Le-Cre;Ptenflox/flox;Fgfr2flox/flox
(PtenCKO;Fgfr2CKO) animals were significantly reduced as
compared to PtenCKO mice, suggesting a Fgf10-Fgfr2 autocrine
feedback loop (Figure 4M). Most importantly, PtenCKO;Fgfr2CKO
animals displayed a thin layer of epidermis similar to that of WT
mice, and no tumor was ever observed during their lifespan forn
n Pten levels and upregulation of pAKT, p4EBP1, and pS6. Although there were
d in PtenCKO mice.
suprabasal state) showed increased levels of pAkt, p4EBP1, pS6, and Fgf10.
taining in the PtenCKO facial skin.
S6, and FGF10 levels in human primary keratinocytes.
akly for PTEN but strongly for FGF10 in the epidermal layer. Arrows point to
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up to 2 years (Figures 4I–4N, arrows). Therefore, Pten-deficient
epidermal tumorigenesis requires Fgf10-Fgfr2 signaling.
DISCUSSION
In this study, we showed that hyperactivation of mTOR in Pten-
deficient epidermis translationally stimulated expression of
Fgf10 protein. The resulting activation of Fgfr2 in keratinocytes
forms a positive autocrine feedback loop that is both necessary
and sufficient for the development of skin SCC. FGF ligands are
generally thought to be regulated transcriptionally to achieve
tissue-specific expression patterns. In particular, it has been
well established that stromal induction of Fgf10 and its binding
to Fgfr2 in the epithelia are critical for limb induction, branching
morphogenesis, and skin development (Beenken and Moham-
madi, 2009; Turner and Grose, 2010). However, in contrast to
the paracrine function of Fgf10 common in embryonic develop-
ment, we showed that Pten deletion led to an autocrine Fgf10
signaling in skin SCC. The presence of an mTORC1-regulated
TOP-like sequence in Fgf10 mRNA suggests that ectopic Fgf10
expression in skin keratinocytes is induced by constitutive
mTOR signaling. Indeed, by exploring the different target speci-
ficities of mTORC1 inhibitors Torin and rapamycin, we showed
that phosphorylation of 4EBPs but not S6Ks by mTORC1 is crit-
ical for translational activation of the Fgf10 TOP-like sequence.
Furthermore, genetic disruption of mTORC1 complex not only
prevented overexpression of Fgf10 protein but also suppressed
tumorigenesis in Pten-deficient epidermis. Our results thus
revealed a translational mechanism of FGF signaling activation
by Pten-PI3K-mTOR signaling in skin SCC. To date, FGF
signaling deregulation in cancer has been primarily scrutinized
at the genomic level for geneticmutations or at the transcriptomic
level formRNAmisexpression (Turner andGrose, 2010).Our find-
ings suggest that proteomic analysis of FGF signaling is a prom-
ising venue to identify aberrant FGF signaling in carcinogenesis.
To ensure cutaneous tissue homeostasis, a fine balance of
FGF signaling and its consequent mitogenic effects must be
maintained. There is compelling evidence that Fgfr2 has
tumor-suppressive function in normal keratinocytes because
Fgfr2-deficient animals are more prone to develop skin tumors
in response to chemical carcinogens (Grose et al., 2007). On
the other hand, previous studies have shown that excessive
expression of Fgfr2 ligand, Fgf7, could lead to epidermal hyper-
plasia and gross transformation, and p63-induced Fgfr2 overex-
pression was essential for survival of autochthonous SCCs
(Chikama et al., 2008; Guo et al., 1993; Ramsey et al., 2013).
We now present genetic evidence that loss of Fgfr2 signaling
completely blocked tumorigenesis in Pten-deficient epidermis,Figure 3. mTOR Signaling Is Required for Upregulation of Fgf10
(A) Alignment of RefSeq gene with mouse genome shows that Fgf10mRNA has a
four nucleotides of the transcription start site. The Fgf10 50 UTR sequences ca
(mutTOP) were cloned into GFP reporter vectors.
(B) In transfected NIH 3T3 cells, Torin suppresses phosphorylation of S6 and 4EB
(Rap) treatment, however, abolished S6 phosphorylation but left 4EBP1 phospho
(C) A reduction in the levels of mTORC1 downstream effectors (p4EBP1 and pS6
(D–P) Phenotypic comparison of facial skin in WT (n = 9), PtenCKO (n = 9), Pte
hyperkeratosis (L) and loss of Fgf10 (P) were observed in PtenCKO;RaptorCKO mi
mean ± SEM. White and black arrows point to facial skin (E–H) and epidermis (I–demonstrating that Fgfr2 is important for the pathogenesis of
skin SCC. These results thus raise the conundrum of how FGF
signaling can be both tumor suppressive and oncogenic in the
epidermis. We would like to suggest that these two opposing
functions of FGF signaling may be explained by different magni-
tudes of signaling activity. In this view, FGF signaling at the phys-
iological level is required for proper skin development and
homeostasis, lack of which results in abnormal skin barrier, path-
ological inflammation, and deficient tumor surveillance. The
Fgfr2 deficiency could be exacerbated by the normal function
of Pten, which is expected to further dampen overall mitogenic
signaling. This explains the apparent paradox that Fgfr2 deletion
induces epidermal hyperplasia only in the presence of WT Pten,
an archetypical tumor suppressor gene. Excessive FGF
signaling, however, promotes cell proliferation and survival,
potentiates cell migration and invasion, and attracts angiogen-
esis. These oncogenic effects may be especially potent in
Pten-deficient epidermis, where an Fgf10-Fgfr2 autocrine feed-
back loop greatly amplifies FGF signaling. Therefore, FGF
signaling can act as an important potentiating factor in skin SCC.
EXPERIMENTAL PROCEDURES
Mice
Ptenflox, Fgfr1flox, TCRd/, and R26R mice were obtained from Jackson
Laboratory (Hoch and Soriano, 2006; Itohara et al., 1993; Lesche et al.,
2002; Soriano, 1999). Rictorflox and Raptorflox mice were kindly provided by
Drs. Markus A. Ru¨egg and Michael N. Hall (Biozentrum, University of Basel,
Basel) and Estela Jacinto (UMDNJ-Robert Wood Johnson Medical School,
Piscataway) (Bentzinger et al., 2008). Le-Cre and Fgfr2flox mice were kindly
provided by Dr. Ruth Ashery-Padan (Tel Aviv University, Tel Aviv) and Dr. David
Ornitz (WashingtonUniversityMedical School, St. Louis), respectively (Ashery-
Padan et al., 2000; Yu et al., 2003). Fgf10 conditional transgenic mouse (pMes-
Fgf10) was previously described by Song et al. (2013). All animal experiments
were performed according to IACUC regulations.
Histology and Immunohistochemistry
Histology and immunohistochemistry were performed as previously
described by Pan et al. (2010). Human specimens of normal skin, SCC, and
SCC occurring after solid organ transplantation (SOT) were obtained after
approval from IRB at Indiana University School of Medicine. For histopatho-
logical analysis, 5 mm sections obtained from formalin-fixed paraffin-
embedded skin tissue were used. Image analysis of histology data was
performed using ImageJ. The relative pixel intensity in gray scale ranging
from 0 to 255 was obtained by measuring a specified area at three different
locations on the same section. Each data point was calculated by taking the
average of pixel intensity for three separate images of the same section,
and analyzed by one-way ANOVA.
Western Blot
Facial hair was removed using Nair hair removal cream, and skin around the
cheek and eyelid area was dissected out in one piece, snap-frozen, and storedTOP-like sequence motif, defined as containing at least five pyrimidines within
rrying either WT TOP-like sequence (wtTOP) or 6 bp transversion mutations
P1, and expression of GFP in WT but not mutant Fgf10 reporters. Rapamycin
rylation partially reduced and GFP expressions unchanged.
) and Fgf10 was seen in lysates from PtenCKO;RaptorCKO mice.
nCKO;RictorCKO (n = 9), and PtenCKO;RaptorCKO (n = 3) mice. Rescue of the
ce. One-way ANOVA: *p < 0.001; N.S., not significant. Data are presented as
P), respectively.
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Figure 4. Fgf10-Fgfr2 Signaling Potentiates Pten Deletion-Induced SCC
(A) Schematics of pMef-Fgf10 transgene. After crossingwith Le-Cre driver, excision of STOP cassette in pMef-Fgf10 transgene permits constitutive expression of
Fgf10 in skin epidermis.
(B) Fgf10 expression increased in papillomas obtained from Le-Cre;pMef-Fgf10 mice.
(C–F) Papillomas appeared in Le-Cre;pMef-Fgf10 cheek and eyelid regions (arrows).
(G–L) Epidermal hyperplasia phenotype seen in PtenCKO animals was modestly reduced in PtenCKO;Fgfr1CKO but abolished in PtenCKO;Fgfr2CKO mice (arrows).
(M) Immunoblots showed reduced pAKT and Fgf10 levels in PtenCKO;Fgfr2CKO epidermal lysates.
(N) Measurements of epidermal thickness in WT (n = 9), PtenCKO (n = 9), PtenCKO;Fgfr1CKO (n = 3), and PtenCKO;Fgfr2CKO (n = 9) mice are shown as mean ± SEM.
One-way ANOVA: *p < 0.001.at80C until usage. The dissected skin samples were then carefully scraped
with a curette to selectively remove only the epidermal layer, which was lysed
in RIPA buffer containing protease inhibitors. Equal amounts of the lysates
were separated on SDS-PAGE, and the blots stained with primary antibodies
were visualized using IRDye-linked secondary antibody in Odyssey SA
scanner (LI-COR Biosciences) as previously described by Qu et al. (2011).
Antibodies used are specific to Actin (Abcam), GFP (a gift from Dr. Pamela
Silver, Harvard Medical School, Boston), Ki67 (BD PharMingen), Keratin 10,
Keratin 14, phospho-4E-BP1T37/46, phospho-S6S235/236, phospho-AktS473,
and Pten (all from Cell Signaling Technology), phospho-Histone H3 (Upstate),
and Fgf1, Fgf2, Fgf7, and Fgf10 (all from Santa Cruz Biotechnology). At least
three mice of each genotype were analyzed.
Keratinocyte Culture
Skins removed from neonatal pups were washed in DPBS plus 2% antibiotics,
stretched out (dermis side down) on autoclaved filter paper in a 100mmculture824 Cell Reports 6, 818–826, March 13, 2014 ª2014 The Authorsplate, and digested overnight at 4C in 0.25% trypsin. The epidermis was next
gently separated from the dermis, finely minced, washed once, and filtered
through a 70 mm cell strainer. Isolated keratinocytes were plated in keratino-
cyte serum-free media supplemented with growth factors and 0.2 mM CaCl2
(Invitrogen) and maintained at 37C/5% CO2 with media changed every
2 days. Keratinocyte differentiation from basal to suprabasal stage was
induced by increasing the Ca2+ concentration to 1.2 mM in the culture media.
At 70% confluency, keratinocytes were infected overnight with Adeno-Cre
GFP virus (Gene Transfer Vector Core, University of Iowa) at 100 multiplicity
of infection virus parts per cell. At about 90%–100% GFP expression, cells
were lysed in ice-cold RIPA buffer supplemented with protease inhibitors
and used for immunoblotting experiments.
siRNA Transfection
nTERT-immortalized primary human keratinocytes were maintained in EpiLife
keratinocyte media supplemented with human keratinocyte growth cocktail
and 1,000 U penicillin-streptomycin (Invitrogen). At around 60% confluency,
cells were transfected with negative control or siRNA against PTEN
(ON_TARGET plus siRNA; Dharmacon/Fisher Scientific) using Lipofectamine
RNAiMax (Invitrogen) as per manufacturer’s instructions. PTEN knockdown
was analyzed by immunoblotting 72 hr postinfection. siRNA transfection
was performed at both basal and suprabasal stages of keratinocyte
differentiation.Fgf10 TOP-like Sequence Analysis
The entire 50 UTR sequence (675 bp) of the Fgf10 gene was amplified by PCR
from mouse genomic DNA and inserted into the HindIII site within the pEGFP-
N3 vector (Clontech) to generate the wtTOP plasmid. The mutTOP plasmid
contains the same 50 UTR sequence, except the six pyrimidines (CTTTCC)
within the TOP-like sequence were mutated to GAAAGG. The primers used
for cloning are the following: wtTOP forward, 50-GTTAAGCTTGGCTTTCCA
AGGGACTTGGAG-30; mutTOP forward, 50-CGTTAAGCTTGGGAAAGGAGGG
ACTTGGAGGTGGAGAG-30; and TOP reverse, 50-ACCAAGCTTAATGTT
TGGATCGTCATGGG-30. For functional analysis, pEGFP-N3, wtTOP, or
mutTOP plasmids were transfected into NIH 3T3 cells (60% confluency) using
TurboFect reagent (Thermo Scientific). After 24 hr, cells were treated with
mTOR inhibitors Torin 2 (150 nM; R&D Systems) and Rapamycin (100 nM;
Cell Signaling Technology) for another 24 hr before being lysed for immu-
noblotting analysis.Quantitative Real-Time PCR
Total RNAs extracted from skin and keratinocyte samples were converted to
cDNA using the SuperScript III Reverse Transcriptase kit (Invitrogen). qPCR
analysis was performed in 10 ml reactions with the SYBR Green PCR Master
Mix and analyzed on a StepOnePlus Real-Time PCR instrument (Invitrogen).
Relative standard curves were generated by serial dilutions, and all samples
were run in triplicates. Primers used are the following: Fgfr1 (50-GGACACC
GAAGGGCTTTTAT-30 and 50-GGTTTTCTTCCAGCCTTTCC-30), Fgf2 (50-GGC
TGCTGGCTTCTAAGTCT-30 and 50-TTCCGTGACCGGTAAGTATTG-30), Fgf7
(50-GGGAAATGTTCGTTGCCTTA-30 and 50-CCCTGCTGAATGAAACTGGT-
30), Fgf10 (50-CAATGGCAGGCAAATGTATG-30 and 50-GGAGGAAGTGAGCA
GAGGTG-30), Fgf22 (50-CGTGTGGACCTTGGTGG-30 and 50-ACACGGACA
GAACGGATCTC-30), and Gapdh (50-AGGTCGGTGTGAACGGATTTG-30 and
50-TGTAGACCATGTAGTTGAGGTCA-30).SUPPLEMENTAL INFORMATION
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